We are live on
!
Find out more
Sana Biotechnology
SANA
SANA
88 hedge funds and large institutions have $2.48B invested in Sana Biotechnology in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
5,015% more call options, than puts
Call options by funds: $15.5M | Put options by funds: $303K
112% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 17
89% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 9
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
28% more capital invested
Capital invested by funds: $1.93B → $2.48B (+$545M)
10% more funds holding
Funds holding: 80 → 88 (+8)
6.15% more ownership
Funds ownership: 52.38% → 58.53% (+6.2%)
Holders
88
Holders Change
+8
Holders Change %
+10%
% of All Funds
1.54%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.11%
New
17
Increased
36
Reduced
17
Closed
9
Calls
$15.5M
Puts
$303K
Net Calls
+$15.2M
Net Calls Change
+$13.9M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$108M |
| 2 |
BlackRock
New York
|
+$68.9M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.8M |
| 4 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
+$14.6M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.3M |
